Long-acting injectable biologics: a game-changer in immunopharmacology
Long-acting injectable (LAI) biologics, a class of agents consisting of a biologically active compound – the active pharmaceutical ingredient (API) – and polymers that form a microparticle, suspension, or hydrogel, have recently emerged as a potentially revolutionizing modality in immunopharmacology...
Saved in:
| Main Authors: | Ayat Abdulkhaleq Jawad, Zainab M. Abdulkhaleq, Amjad I. Oraibi, Mostafa Adnan abdalrahman, Haithem N. Abed, Hiba A. Aziz, Sura Sagban Abid Ali, Dhuha Mahdi Al-bahrani, Usama S. Altimari, Mohammed Abed Jawad, Hany Akeel Al-hussaniy |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Pensoft Publishers
2025-08-01
|
| Series: | Pharmacia |
| Online Access: | https://pharmacia.pensoft.net/article/154045/download/pdf/ |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Efficient quantum of mechanical simulation of diffusion-weighted MRI
by: Ahmed J. Allami, et al.
Published: (2024-12-01) -
Immunopharmacological aspects of the cytokine system
by: A. S. Simbirtsev
Published: (2019-05-01) -
Reading English as a foreign language: The interplay of abilities and strategies
by: Abdulkhaleq Abdulhadi Al-Qahtani
Published: (2021-01-01) -
Conflict-Induced Migration and Economic Opportunities: The Integration of Yemeni Migrants in Indonesia Amidst the Ongoing Yemeni Crisis
by: Abdulkhaleq Ali Ahmed Al-Rawafi
Published: (2025-02-01) -
Immunopharmacology of gastric cancer–deciphering immune cell subset responses and nanoparticle-mediated targeting
by: Yanting Wang, et al.
Published: (2025-05-01)